| Literature DB >> 22403694 |
Paolo Tieri1, Alberto Termanini, Elena Bellavista, Stefano Salvioli, Miriam Capri, Claudio Franceschi.
Abstract
Inflammation is part of a complex physiological response to harmful stimuli and pathogenic stress. The five components of the Nuclear Factor κB (NF-κB) family are prominent mediators of inflammation, acting as key transcriptional regulators of hundreds of genes. Several signaling pathways activated by diverse stimuli converge on NF-κB activation, resulting in a regulatory system characterized by high complexity. It is increasingly recognized that the number of components that impinges upon phenotypic outcomes of signal transduction pathways may be higher than those taken into consideration from canonical pathway representations. Scope of the present analysis is to provide a wider, systemic picture of the NF-κB signaling system. Data from different sources such as literature, functional enrichment web resources, protein-protein interaction and pathway databases have been gathered, curated, integrated and analyzed in order to reconstruct a single, comprehensive picture of the proteins that interact with, and participate to the NF-κB activation system. Such a reconstruction shows that the NF-κB interactome is substantially different in quantity and quality of components with respect to canonical representations. The analysis highlights that several neglected but topologically central proteins may play a role in the activation of NF-κB mediated responses. Moreover the interactome structure fits with the characteristics of a bow tie architecture. This interactome is intended as an open network resource available for further development, refinement and analysis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22403694 PMCID: PMC3293857 DOI: 10.1371/journal.pone.0032678
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The three interactomes DI (a), UI (b) and MCI (c) and the resulting UNION interactome (d) as from Cytoscape layout, available in the Dataset S1 as .cys file.
Datasets and interactomes have been reconstructed following procedures described in materials and methods section. Nodes represent proteins and links are evidence-based physical interactions. Node size and color are proportional to betweenness centrality values (red: high, green: low; not comparable among different interactomes). Isolated proteins show no evidence of physical interactions with any other proteins within the same dataset.
summary of main network parameters of NF-κB upstream protein interactomes DI, UI, MCI and UNION and overrepresented KEGG pathways (p<0.05).
|
|
|
|
|
|
|
|
|
|
| 377 | 4119 | 21.1/0.056 | 0.591 | hsa03010 Ribosome | 28.8 | 7.2 |
| hsa03050 Proteasome | 21.8 | 3.2 | |||||
| hsa04623 Cytosolic DNA-sensing pathway | 21.4 | 3.2 | |||||
| hsa04622 RIG-I-like receptor signaling pathway | 19.7 | 4.0 | |||||
| hsa05215 Prostate cancer | 18.9 | 4.5 | |||||
| hsa04621 NOD-like receptor signaling pathway | 18.9 | 3.5 | |||||
| hsa04662 B cell receptor signaling pathway | 18.7 | 3.7 | |||||
| hsa04920 Adipocytokine signaling pathway | 18.0 | 3.7 | |||||
| hsa04620 Toll-like receptor signaling pathway | 17.6 | 5.0 | |||||
| hsa03020 RNA polymerase | 17.1 | 1.6 | |||||
|
| 210 | 568 | 4.6/0.022 | 0.185 | hsa04623 Cytosolic DNA-sensing pathway | 40.0 | 9.6 |
| hsa04622 RIG-I-like receptor signaling pathway | 32.0 | 10.5 | |||||
| hsa04621 NOD-like receptor signaling pathway | 29.4 | 8.7 | |||||
| hsa04620 Toll-like receptor signaling pathway | 26.2 | 12.2 | |||||
| hsa03020 RNA polymerase (22.9) | 22.9 | 3.5 | |||||
| hsa04210 Apoptosis | 18.5 | 7.4 | |||||
| hsa04662 B cell receptor signaling pathway | 17.6 | 5.7 | |||||
| hsa04920 Adipocytokine signaling pathway | 16.9 | 5.7 | |||||
| hsa05222 Small cell lung cancer | 14.4 | 5.7 | |||||
| hsa04660 T cell receptor signaling pathway | 13.2 | 6.6 | |||||
|
| 141 | 853 | 11.0/0.078 | 0.232 | hsa03050 Proteasome | 54.0 | 19.2 |
| hsa04210 Apoptosis | 27.2 | 17.7 | |||||
| hsa04662 B cell receptor signaling pathway | 21.6 | 11.4 | |||||
| hsa04620 Toll-like receptor signaling pathway | 20.6 | 15.6 | |||||
| hsa04622 RIG-I-like receptor signaling pathway | 20.0 | 10.6 | |||||
| hsa04621 NOD-like receptor signaling pathway | 19.1 | 9.2 | |||||
| hsa05222 Small cell lung cancer | 17.8 | 11.4 | |||||
| hsa04920 Adipocytokine signaling pathway | 16.9 | 9.2 | |||||
| hsa04660 T cell receptor signaling pathway | 16.7 | 13.5 | |||||
| hsa04722 Neurotrophin signaling pathway | 16.7 | 14.9 | |||||
|
| 622 | 6115 | 18.9/0.030 | 0.360 | hsa03050 Proteasome | 62.0 | 5.0 |
| hsa04621 NOD-like receptor signaling pathway | 40.6 | 4.5 | |||||
| hsa04620 Toll-like receptor signaling pathway | 38.0 | 6.6 | |||||
| hsa04623 Cytosolic DNA-sensing pathway | 37.5 | 3.4 | |||||
| hsa03020 RNA polymerase | 34.3 | 1.9 | |||||
| hsa04622 RIG-I-like receptor signaling pathway | 34.2 | 4.2 | |||||
| hsa04210 Apoptosis | 33.3 | 5.0 | |||||
| hsa04662 B cell receptor signaling pathway | 30.7 | 3.7 | |||||
| hsa05222 Small cell lung cancer | 29.7 | 4.3 | |||||
| hsa03010 Ribosome | 28.7 | 4.3 |
See main text for further comments and explanations. Complete datasets available in Table S3.
Figure 2Datasets DI, U and MC share a relatively low number of proteins, as reported by the figures in the intersections.
Datasets are quite differentiated in their composition and share only the 2.6% of the whole UNION set (16 out of 622).
First 25 most central proteins (betweenness centrality) in UNION interactome (in bold the NF-κB components).
| Rank | Protein ID | Betwn Centr | Protein description | NCBI gene name |
| 1 |
| 0.21071004 |
| RELA |
| 2 |
| 0.08342206 |
| NFKB1 |
| 3 | TRAF6 | 0.07545745 | TNF receptor-associated factor 6 | TRAF6 |
| 4 |
| 0.07071487 |
| NFKB2 |
| 5 |
| 0.0393886 |
| RELB |
| 6 | NEMO | 0.03913555 | NF-kappa-B essential modulator | IKBKG |
| 7 | TRAF2 | 0.03567854 | TNF receptor-associated factor 2 | TRAF2 |
| 8 | SRC | 0.03049217 | Proto-oncogene tyrosine-protein kinase Src | SRC |
| 9 | UBIQ | 0.02940406 | Ubiquitin | RPS27A |
| 10 | IKKB | 0.02905882 | Inhibitor of nuclear factor kappa-B kinase subunit beta | IKBKB |
| 11 | HSP7C | 0.02826285 | Heat shock cognate 71 kDa protein | HSPA8 |
| 12 | IKKE | 0.02712651 | Inhibitor of nuclear factor kappa-B kinase subunit epsilon | IKBKE |
| 13 | MYC | 0.0253939 | Myc proto-oncogene protein | MYC |
| 14 | HS90A | 0.02399683 | Heat shock protein HSP 90-alpha | HSP90AA1 |
| 15 | ESR1 | 0.02195341 | Estrogen receptor | ESR1 |
| 16 | IKKA | 0.02094338 | Inhibitor of nuclear factor kappa-B kinase subunit alpha | CHUK |
| 17 | BTK | 0.0202242 | Tyrosine-protein kinase BTK | BTK |
| 18 | IRAK1 | 0.01966103 | Interleukin-1 receptor-associated kinase 1 | IRAK1 |
| 19 | M3K3 | 0.01862895 | Mitogen-activated protein kinase kinase kinase 3 | MAP3K3 |
| 20 | P53 | 0.0165347 | Tumor suppressor gene p53 | TP53 |
| 21 |
| 0.01543792 |
| REL |
| 22 | RIPK2 | 0.01533207 | Receptor-interacting serine/threonine-protein kinase 2 | RIPK2 |
| 23 | BCL10 | 0.01434518 | B-cell lymphoma/leukemia 10 | BCL10 |
| 24 | IKBA | 0.01433697 | NF-kappa-B inhibitor alpha | NFKBIA |
| 25 | STAT3 | 0.01373161 | Signal transducer and activator of transcription 3 | STAT3 |
Overrepresented pathways in DG (p<0.05), first 20 terms ranked for percentage of DG proteins present in KEGG pathway (“% of set” column).
| KEGG ID | Pathway | Total terms in KEGG pathway | Terms in set and pathway | % of set | % of pathway |
|
| Cytokine-cytokine receptor interaction | 271 | 70 | 17,07 | 25,83 |
|
| Chemokine signaling pathway | 186 | 30 | 7,32 | 16,13 |
|
| Jak-STAT signaling pathway | 154 | 26 | 6,34 | 16,88 |
|
| Toll-like receptor signaling pathway | 101 | 23 | 5,61 | 22,77 |
|
| Small cell lung cancer | 90 | 19 | 4,63 | 21,11 |
|
| NOD-like receptor signaling pathway | 62 | 17 | 4,15 | 27,42 |
|
| Prostate cancer | 88 | 17 | 4,15 | 19,32 |
|
| Apoptosis | 86 | 16 | 3,90 | 18,60 |
|
| Type I diabetes mellitus | 90 | 16 | 3,90 | 17,78 |
|
| Intestinal immune network for IgA production | 84 | 15 | 3,66 | 17,86 |
|
| Allograft rejection | 84 | 15 | 3,66 | 17,86 |
|
| Hematopoietic cell lineage | 87 | 15 | 3,66 | 17,24 |
|
| Graft-versus-host disease | 87 | 13 | 3,17 | 14,94 |
|
| Bladder cancer | 42 | 12 | 2,93 | 28,57 |
|
| p53 signaling pathway | 67 | 11 | 2,68 | 16,42 |
|
| Melanoma | 70 | 11 | 2,68 | 15,71 |
|
| Pancreatic cancer | 71 | 11 | 2,68 | 15,49 |
|
| Cytosolic DNA-sensing pathway | 55 | 10 | 2,44 | 18,18 |
|
| Primary immunodeficiency | 41 | 9 | 2,20 | 21,95 |
|
| Amyotrophic lateral sclerosis | 57 | 9 | 2,20 | 15,79 |
“Feedback” genes and related proteins (protein ID alphabetical order).
| Protein ID | Protein Description | NCBI gene name |
| ANDR | Androgen receptor | AR |
| BCL3 | B-cell lymphoma 3-encoded protein | BCL3 |
| BIRC4 | Baculoviral IAP repeat-containing protein 4 | BIRC4 |
| BLNK | B-cell linker protein | BLNK |
| BTK | Tyrosine-protein kinase BTK | BTK |
| CAV1 | Caveolin-1 | CAV1 |
| CFLAR | CASP8 and FADD-like apoptosis regulator | CFLAR |
| EGR1 | Early growth response protein 1 | EGR1 |
| ELF3 | ETS-related transcription factor Elf-3 | ELF3 |
| ERBB2 | Receptor tyrosine-protein kinase erbB-2 | ERBB2 |
| GCR | Glucocorticoid receptor | NR3C1 |
| HS90A | Heat shock protein HSP 90-alpha | HSP90AA1 |
| IKBA | NF-kappa-B inhibitor alpha | NFKBIA |
| IKBE | NF-kappa-B inhibitor epsilon | NFKBIE |
| IKBZ | NF-kappa-B inhibitor zeta | NFKBIZ |
| IL2RA | Interleukin-2 receptor alpha chain | IL2RA |
| IL32 | Interleukin-32 | IL32 |
| IRF1 | Interferon regulatory factor 1 | IRF1 |
| IRF2 | Interferon regulatory factor 2 | IRF2 |
| KISS1 | Metastasis-suppressor KiSS-1 | KISS1 |
| LYSC | Lysozyme C | LYZ |
| MYC | Myc proto-oncogene protein | MYC |
|
| Nuclear factor NF-kappa-B p105 subunit | NFKB1 |
|
| Nuclear factor NF-kappa-B p100 subunit | NFKB2 |
| NOD2 | Nucleotide-binding oligomerization domain-containing protein 2 | NOD2 |
| NUAK2 | NUAK family SNF1-like kinase 2 | NUAK2 |
| OLR1 | Oxidized low-density lipoprotein receptor 1 | OLR1 |
| P53 | Tumor suppressor gene p53 | TP53 |
| PRGR | Progesterone receptor | PGR |
| PSA2 | Proteasome subunit alpha type-2 | PSMA2 |
| PSB9 | Proteasome subunit beta type-9 | PSMB9 |
| PTEN | Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase PTEN | PTEN |
|
| C-Rel proto-oncogene protein | REL |
|
| Transcription factor RelB | RELB |
| RIPK2 | Receptor-interacting serine/threonine-protein kinase 2 | RIPK2 |
| TCAM1 | TIR domain-containing adapter molecule 1 | TICAM1 |
| TERT | Telomerase reverse transcriptase | TERT |
| TGM2 | Protein-glutamine gamma-glutamyltransferase 2 | TGM2 |
| TIFA | TRAF-interacting protein with FHA domain-containing protein A | TIFA |
| TLR2 | Toll-like receptor 2 | TLR2 |
| TLR9 | Toll-like receptor 9 | TLR9 |
| TNAP3 | Tumor necrosis factor, alpha-induced protein 3 | TNFAIP3 |
| TNF15 | Tumor necrosis factor ligand superfamily member 15 | TNFSF15 |
| TNIP1 | TNFAIP3-interacting protein 1 | TNIP1 |
| TNIP3 | TNFAIP3-interacting protein 3 | TNIP3 |
| TRAF1 | TNF receptor-associated factor 1 | TRAF1 |
| TRAF2 | TNF receptor-associated factor 2 | TRAF2 |
| TWST1 | Twist-related protein 1 | TWIST1 |
| VIME | Vimentin | VIM |
NF-κB controls the transcription of hundreds of genes. Forty-nine of them code for proteins that belong to the UNION interactome, i.e. that participate in the activation of NF-κB. The circuit “interaction with NF-κB pathway → transcription factor activation → transcriptional regulation → interaction with NF-κB pathway” establishes a number of feedback loops that can play a role in the dynamics of the NF-κB system. In bold the four NF-κB components which transcription is regulated by NF-κB itself.
Figure 3The UNION interactome is composed by 622 proteins, including the five NF-κB subunits.
NF-κB is able to regulate the expression of 426 proteins (DG set, see main text). A subset (384 proteins, present in the APID database, out of 426) has been checked for PPIs (see Dataset S1). Forty nine proteins are shared by both the UNION and the DG sets, establishing a feedback loop: “interaction with NF-κB pathway → transcription factor activation → transcriptional regulation → interaction with NF-κB pathway”, meaning that 13% of the identified NF-κB-regulated genes express proteins that play a direct role in the UNION interactome.